Member Info for Kevinl1977

This will be exactly the same information, unless we unearth some more data rich facts by then.
If this is the case, then we would find out first via an RNS.

Viking
It’s such a simple thing to calculate; I’m amazed they didn’t know with the first patient.

CJ
Maybe you need to email the head of comms then for an update. You won’t get much back, as anything price sensitive will need to be RNSsd.
Reminder of what AI said recently:
Next step higher dose concluded by this half year. Next part is dose expansion focus 1/2 cancer types 20 patients for soft tissue sarcoma begins asap later this year. In UK and 2 places being lined up in the US.
Will stay patient and see.

RMF
Agreed, posting the facts rather than garbage.
Some posters expecting RNSs every week and lots of news when lengthy trials are happening.
Good post.

Yes, I’m sure hiring top quality staff is a backwards step.
I’m sure Avacta could reach cutting edge oncology stage paying a few staff the minimum wage:
Loon

Is excellent.
Keep buying, even though mine showed up as a sell earlier.

Intriguing read.
Excellent post, many thanks Mr R.

What a ridiculously stupid post, worst of the short week by far.

Think we all know how AIM works.
Slowly drop a price, to rinse out the weak.
Then, when really positive news lands we jump back up to what it was originally and everyone thinks woopeee.
It then gets manipulated and drops again.
Game playing, as per.

Sorry Timster.
Maybe I should give you my prediction for the SP each day.
Would that be better?

https://www.msn.com/en-gb/money/finance/as-stock-markets-dive-heres-warren-buffetts-advice/ar-AA18NaOD?ocid=mailsignout&li=BBoPWjQ

Excellent news.

Robbo
No disrespect, but can’t see it.
Hope you’re right, of course.

Timster
Yes, I think I get that he means in the 140’s!

Below start of day trading price, Hurst for no apparent reason?
Low volume, also.

GMCC
Thanks for your sleuthing, yet again.
ATB.

No!!

RAH
Absolutely agree, especially point 3.

Good luck, Mowzer.

System
Of course it’s a high risk investment, a mixture in your portfolio is sensible.
It’s a pharmaceutical company. Most of these are involved in drug trials, some gain FDA approval, some don’t.
What don’t you understand?
You aren’t invested here, so why post things?
Pretty sad if you ask me.
This is a company that could potentially save yours or one of your friends/family’s life. This disease affects 1 in 2 people.
The CEO wants a life saving treatment that is accessible to everyone. A pretty impressive vision if you ask me.
The science day was there for everyone to see. One of the most esteemed oncologists in the World attended.
Just saying…